baber/WOPTO huggingface dataset:
Patent NZ-264340-A (NZ)
Title: Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
Inventor: VAN BOECKEL CONSTANT ADRIAAN A
IPC: A61K47/48
Filed: 1994-08-30
Abstract: The invention relates to a tuneable bisconjugate comprising two saccharides and a spacer, each saccharide being the same or different and comprising two to six monosaccharide units, at least one unit being uronic acid, characterized in that at least one of the saccharides per se has anti-thrombotic activity, and that the spacer connects at least one saccharide to the other through its non-reducing end, the chain length of the spacer being 20-120 atoms.
Patent NZ-268414-A (NZ)
Title: Liquid dispenser including a vent mechanism to vent gas from a pressure control chamber to drive a reciprocatable pumping member through a stroke to draw liquid
Inventor: GROSS JOSEPH
IPC: A61M37/00
Filed: 1994-07-15
Abstract: PCT No. PCT/IE94/00037 Sec. 371 Date Mar. 27, 1996 Sec. 102(e) Date Mar. 27, 1996 PCT Filed Jul. 15, 1994 PCT Pub. No. WO95/03078 PCT Pub. Date Feb. 2, 1995A liquid material dispenser, for use, for example, in dispensing liquid medicine over an extended period of time, which includes a housing (10) enclosing a reservoir (12) for storing the liquid to be dispensed and having an outlet (14) through which the liquid is dispensed, and a connecting passageway (16) between the reservoir and the outlet. Located in the passageway is a diaphragm (18), one side of which defines a pumping chamber (20) and the other side of which defines a pressure control chamber (22). The diaphragm (18) is cyclically displaceable through a pumping stroke for pumping liquid through the outlet (14) and a drawing stroke for drawing liquid from the reservoir (12). Also located in the passageway (16) are a pair of valves (30, 33) which serve, during the drawing stroke, to cause the diaphragm (18) to draw liquid from the reservoir (12) into the pumping chamber (20), and during the pumping stroke, to cause the diaphragm (18) to pump liquid from the pumping chamber (20) through the outlet (14). An electrolytic cell (24) generates gas at suitable times for suitable durations and rates which is supplied to the pressure control chamber (22) to drive the pumping member (18) through the pumping stroke. A vent is used for venting the gas from the pressure control chamber (22) to the atmosphere to drive the pumping member (18) through the drawing stroke. The vent has an inlet vent opening (40) inside the pressure control chamber (22), with the opening (40) being caused to open to end the pumping stroke and to close after a portion of the gas has vented.
Patent NZ-280542-A (NZ)
Title: Powder coating consisting essentially of cellular spherical particles
Inventor: DALY ANDREW T
IPC: C09D5/03
Filed: 1995-11-28
Abstract: A coating powder consisting essentially of generally spherical, preferably cellular, particles ranging in size from less than 2 to 40 mu m, 75% of whose volume consist of particles of from 2 to 20  mu m in size, is provided by dissolving the components of the coating powder in a supercritical fluid without the aid of a surfactant and spraying the solution into a zone whose pressure is less than that of the fluid. A very smooth continuous film of a cured thermosettable coating powder is achieved even when the film thickness is less than 25.4  mu m (1 mil), e.g. from 5  mu m (about 0.2 mil) and greater. The advantages of powder coatings may now be realised fully in the automobile and can industries. <IMAGE>
Patent NZ-330118-A (NZ)
Title: Thiophenopyrimidines, pharmaceutical compositions thereof and use in treating endocrine, psychiatric and neurologic conditions
Inventor: CHEN CHEN
IPC: A61P25/18
Filed: 1998-01-30
Abstract: This application concerns compounds of formula (I) including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein X is S, SO or SO2; R1 is NR4R5 or OR5; R2 is C1-6alkyl, C1-6alkyloxy or C1-6alkylthio; R3 is hydrogen, C1-6alkyl, C1-6alkylsulfonyl, C1-6alkylsulfoxy or C1-6alkylthio; R4 is hydrogen, C1-6alkyl, mono- or di(C3-6cycloalkyl)methyl, C3-6cycloalkyl, C3-6alkenyl, hydroxyC1-6alkyl, C1-6alkylcarbonyloxyC1-6alkyl or C1-6alkyloxyC1-6alkyl; R5 is C1-8alkyl, mono- or di(C3-6cycloalkyl)methyl, Ar1CH2, C1-6alkyloxy-C1-6alkyl, hydroxyC1-6alkyl, C3-6alkenyl, thienylmethyl, furanylmethyl, C1-6alkylthioC1-6 alkyl, morpholinyl, mono- or di(C1-6alkyl)aminoC1-6alkyl, di(C1-6alkyl)amino, C1-6alkylcarbonylC1-6alkyl, C1-6alkyl substituted with imidazolyl; or a radical of the formula: -Alk-O-CO-Ar1; or R4 and R5 taken together with the nitrogen atom to which they are attached may form an optionally substituted pyrrolidinyl, piperidinyl, homopiperidinyl or morpholinyl group; Ar is a phenyl, substituted phenyl, pyridinyl or substituted pyridinyl; having CRF receptor antagonistic properties; pharmaceutical compositions containing such compounds as active ingredients; methods of treating disorders related to hypersecretion of CRF such as depression, anxiety, substance abuse, by administering an effective amount of a compound of formula (I).
Patent NZ-332807-A (NZ)
Title: Emulsions of perfluoro compounds and nitric oxide, the perfluoro compounds act as solvents for nitric oxide
Inventor: GARFIELD R
IPC: A61P9/12
Filed: 1997-04-16
Abstract: A perfluoro compound emulsion also containing nitric oxide is claimed. The nitric oxide-containing emulsions maybe used for the administration of nitric oxide to individuals suffering from hypertension, pre-eclampsia and other disorders where an increased blood flow is desirable.
Patent NZ-333020-A (NZ)
Title: Fish growth hormone
Inventor: BAN TAKAYUKI
IPC: C07K14/61
Filed: 1998-03-23
Abstract: The specification describes polypeptides with fish growth hormone-like activity. Specifically described is a Anacystis nidulans PCC6301old which is transformed with pBAX18fGH.  The polypeptide may be formulated into a fish feed.
Patent NZ-333322-A (NZ)
Title: Di-N-substituted piperazines and 1,4-di-substituted piperidines as muscarinic antagonists
Inventor: KOZLOWSKI JOSEPH A
IPC: C07D295/096
Filed: 1997-06-26
Abstract: The specification describes Di-N-substituted piperazine or 1,4-di-substituted piperidine compounds in accordance with above formula (I) (including all isomers, salts, esters, and solvates), Variables Q, n, R, R1, R2, R3, R4, R21, R27, R28, X, and Z are as defined in the specification itself.  The  muscarinic antagonists are useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed as are synergistic combinations with acetylcholinesterase inhibitors.
Patent NZ-333887-A (NZ)
Title: Alkenyl succinic anhydride (ASA) emulsions containing low and high molecular weight cationic polymers and use for sizing paper
Inventor: GLOVER DANIEL E
IPC: D21H17/16
Filed: 1997-06-25
Abstract: These ASA sizing emulsions contain low and high molecular weight cationic. The ASA sizing emulsion of the application contains: (a) 25 to 99 percent by weight water, (b) 0.003 to 60 percent by weight ASA, (c) 0.003 to 50 percent by weight of a cationic polymer mixture, and (d) 0 to 2 percent by weight of a surfactant. The cationic polymer mixture contains 75 to 99 percent by weight of an ionene polymer and 1 to 25 percent by weight of a high molecular weight polyethyleneimine polymer. In the sizing emulsion, the ASA has a particle size ranging from 0.5 to 3 microns. A method for sizing paper using such an emulsion is also described.
Patent NZ-334283-A (NZ)
Title: Polymer-based prodrugs with molecular weights greater than 20,000 which comprise non-antigenic polymers
Inventor: GREENWALD RICHARD B
IPC: A61K47/48
Filed: 1997-08-20
Abstract: A water soluble prodrug of formula D-Y'-C(=Y)-[C(R1)(R2)]n-X-R3 is claimed wherein: D is a residue of biologically active moiety; X is an electron withdrawing group; Y and Y' are independently O or S; n is zero or a positive integer R1 and R2 are independently H, alkyl or optionally substituted aryl, aralkyl or heteroaryl; R3 is a substantially non-antigenic polymer, optionally substituted alkyl or cycloalkyl, carboxyalkyl, carboalkoxyalkyl, dialkylaminoalkyl, phenylalkyl, phenylaryl or -NR4R5 and R4 and R5 are independently H, alkyl or optionally substituted aryl, aralkyl, heteroaryl or jointly form a cyclic C5-C7 ring except that R1 and R2 are both not H when n is 1 and R3 is a substantially non-antigenic polymer.
Patent NZ-500539-A (NZ)
Title: An antibody that binds HER2 receptor in a composition for treating endometrial, lung, colon or bladder cancer
Inventor: ANDYA JAMES
IPC: A61K39/395
Filed: 1996-07-23
Abstract: The use of an antibody, which binds HER2 growth factor receptor, in the preparation of a medicament for treating a cancer characterised by an overexpression of the HER2 receptor in a mammal is described.  Cancers suitable for such treatment include, breast, ovarian, stomach, endometrial, salivary gland, lung, kidney, colon and bladder cancer, and ductal carcinoma.
Patent NZ-502145-A (NZ)
Title: Method for fastening a flat strip lamella to the surface of a building component
Inventor: BLEIBLER ALEXANDER
IPC: E04G23/02
Filed: 1998-07-15
Abstract: The invention relates to a method for fastening a flat strip lamella (10) to the surface of a building component (12). According to the inventive method, the face (not shown) of the flat strip lamella (10) is pressed against the surface of the building using an adhesive coating (16) consisting of a reaction resin applied in a paste-like consistency (16) and hardened to form an adhesive joint. The flat strip lamella (10) comprises a plurality of carbon fibres which are embedded in a bonding matrix (not shown) and placed parallel to each other in a longitudinal direction. In order to increase the speed at which the adhesive coating hardens, the invention provides that an electrical current flows through least one part of the carbon fibres (26), heating the flat strip lamella (10) which in turn heats the adhesive coating (16).
Patent NZ-504049-A (NZ)
Title: Process for the sulphurization of hydrotreating catalysts with the addition of orthophthalic acid ester (dimethyl orthophthalate, diethyl orthophthalate or bis(2-ethylhexyl) orthophthalate)
Inventor: BRUN CLAUDE
IPC: B01J27/051
Filed: 2000-04-17
Abstract: A process for the sulphurisation of a metal hydrotreating catalyst which process comprises treating the catalyst with a sulphurisation agent, wherein an orthophthalic acid ester of the formula described is added to the sulphurisation agent. Wherein, R1 and R2 which maybe the same or different, represents an alkyl, cycloalkyl, aryl, alkylaryl radical which comprises up to 18 carbon atoms and which is unsubstituted or substituted by one or more heteroatoms.
Patent NZ-510921-A (NZ)
Title: Aglyco peptide from glycoprotein 10B and methods of use for tumors and schizophrenia
Inventor: BOGOCH SAMUEL
IPC: C07K1/00
Filed: 1999-08-30
Abstract: An isolated glycoconjugate peptide comprises the amino acid sequence of SEQ ID NO:1 or 2. The glycoconjugate can be used in the manufacture of a medicament for inhibiting or preventing the attachment of influenza virus particles to the cells of a human patient and for treating chronic viral infection. Antibodies which specifically recognizes the peptides, therapeutic compositions comprising them, and kits are also described.
Patent NZ-512334-A (NZ)
Title: Therapeutic methods and delivery systems utilizing sex steroid precursors
Inventor: LABRIE FERNAND
IPC: A61K31/57
Filed: 1994-01-19
Abstract: A method for preventing and/or treating vaginal atrophy, hypogonadism, diminished libido, osteoporosis, urinary incontinence, ovarian cancer, uterine cancer, and menopause or contraception in susceptible warm-blooded animals involving administration of dehyropiandrosterone (DHEA), dehydroepiandrosterone-sulfate (DHEA-S) or compounds converted in vivo to either and to pharmaceutical products, including pharmaceutical compositions for delivery of useful active ingredient(s) is disclosed. (62) Divided out of 500513
Patent NZ-522476-A (NZ)
Title: Nitrogen containing fertilizer for plant growth
Inventor: NASHOLM LARS TORGNY
IPC: A01N33/00
Filed: 2001-05-14
Abstract: Use of the L-form of a basic protein amino acid, or a salt thereof (the compound), which is in a growth substrate essentially immobile nitrogen containing fertilizer, for cultivating and raising plants, including: that the compound is added to the growth substrate in the form of an aqueous solution, either alone or in admixture with other fertilizers, as the sole nitrogen source; and that the compound has a concentration within the range of 1 millimole per litre (mM) to 30 millimole per litre (mM).
Patent NZ-523286-A (NZ)
Title: Plastic container having a crystallinity gradient
Inventor: BOYD TIMOTHY J
IPC: B65D8/12
Filed: 2001-06-29
Abstract: A polyethylene terephthalate (PET) container that has a crystallinity gradient through its sidewall is disclosed. The inner density is at least 0.005 g/cc greater than the outer density, while the outer density is a minimum of 1.370 g/cc. The higher crystallinity on the interior surface provides increased resistance to flavour scalping of the contents of the plastic container.
Patent NZ-523414-A (NZ)
Title: Piperidine coumpounds for use as CCR-3 inhibitors
Inventor: HOWE TREVOR JOHN
IPC: A61P43/00
Filed: 2001-07-10
Abstract: A compound of formula I where: Ar1 is phenyl substituted by one or more halogen atoms, Ar2 is phenyl or naphthyl which is unsubstituted or substituted by one or more substituents selected from halogen, cyano, hydroxy, nitro, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy or C1-C8-alkoxycarbonyl, R1 is hydrogen or C1-C8-alkyl optionally substituted by hydroxy, C1-C8-alkoxy, acyloxy, N(R2)R3, halogen, carboxy, C1-C8-alkoxycarbonyl, -CON(R4)R5 or by a monovalent cyclic organic group, R2 and R3 are each independently hydrogen or C1-C8-alkyl, or R2 is hydrogen and R3 is acyl or -SO2R6, or R2 or R3 together with the nitrogen atom to which they are attached denote a 5- or 6- membered heterocyclic group, R4 and R5 are each independently hydrogen or C1-C8-alkyl, or R4 or R5 together with the nitrogen atom to which they are attached denote a 5- or 6- membered heterocyclic group, R6 is C1-C8-alkyl, C1-C8-haloalkyl, or phenyl optionally substituted by C1-C8-alkyl, and n is 1-4. This is with the proviso that when Ar1 is p-chlorophenyl and R1 is hydrogen, Ar2 is not phenyl or p-nitrophenyl. The use of the compound described above to treat conditions mediated by CCR-3 and inflammatory or allergic conditions, such as inflammatory or obstructive airway disease.
Patent NZ-527148-A (NZ)
Title: Novel mixtures of microbial enzymes
Inventor: GALLE MANFRED
IPC: A61P1/14
Filed: 2002-01-16
Abstract: Disclosed are mixtures of microbial enzymes containing a concentrated Rhizopus delemar lipase, an Aspergillus melleus protease and an Aspergillus oryzae amylase. Pharmaceutical preparations containing said mixtures of microbial enzymes are also disclosed. The pharmaceutical preparations are especially suitable for the treatment and/or prophylaxis of maldigestion, especially maldigestion caused by pancreatic insufficiency in mammals and humans.
Patent NZ-527771-A (NZ)
Title: Methods for treating or preventing anxiety
IPC: C07D405/12
Filed: 2000-08-04
Abstract: Disclosed is the use, in the preparation of a pharmaceutical composition for reducing anxiety by increasing ion flow through KCNQ potassium channels in a cell, of a compound able to increase ion flow through KCNQ potassium channels. In the particular the compound is of formula (I), wherein Ar1 and Ar2 are optionally substituted aryl or heteroaryl, X is O, S or N-R1 and the remaining substituents are defined herein.
Patent NZ-532862-A (NZ)
Title: Storage and processing of data related to gaming systems to accommodate large volume of transaction data
Inventor: D AMICO MICHAEL H
IPC: G07F17/32
Filed: 2002-09-19
Abstract: A gaming system (10) includes gaming machines (100, 102, 104, and 106) arranged to receive input data and to generate output data. A central database (24) stores the input data and the output data. A data processing unit 40 includes a local database (46). Unit 40 polls the gaming machines to obtain the output data over a network (12), stores the output data in the local database, transmits the output data over the network to the central database and arranges the data in a format useable by report generating software, obtains the input data from the central database, and stores the input data in the local database for use by the gaming machines.
Patent NZ-542852-A (NZ)
Title: Pharmaceutical compositions of CETP inhibitors
Inventor: SUNAMI MASAKI
IPC: A61K31/167
Filed: 2004-03-17
Abstract: A pharmaceutical composition comprising a substantially crystalline cholesteryl ester transfer protein inhibitor and a water-insoluble concentration-enhancing additive, wherein the cholesteryl ester transfer protein inhibitor is a prodrug that forms 8-[2-([[1-(2- ethylbutyl)cyclohexyl]carbonyl]amino)phenyl] thiol in vivo, and said water-insoluble concentration-enhancing additive is crospovidone. Also disclosed is the use of the composition in the treatment of cardiovascular disorders.
Patent NZ-546646-A (NZ)
Title: Gelatine-free soft caramel containing isomaltulose
Inventor: BERNARD JORG
IPC: A23G3/42
Filed: 2004-10-08
Abstract: Disclosed are gelatine-free soft caramels, containing isomaltulose and methods for production thereof. The gelatine-free soft caramels comprise a soft caramel base mass, containing at least one polysaccharide hydrocolloid as a texturising agent, a crystalline sweetener phase that is formed from isomaltulose, and a non-crsytalline sweetener phase.
Patent NZ-549752-A (NZ)
Title: Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
Inventor: CODD ELLEN C
IPC: A61K31/27
Filed: 2002-07-11
Abstract: Disclosed is the use, in the preparation of a medicament for preventing or treating neuropathic pain, with the proviso that the neuropathic pain is not central post-stroke pain, trigeminal neuralgia or spinal cord injury-associated pain, of a compound of Formula (I) wherein: phenyl is substituted at X with one to five halogen atoms independently selected from the group consisting of fluorine, chlorine, bromine and iodine;and, R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C-4- alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano). (62) Divided Out of 530659
Patent NZ-552315-A (NZ)
Title: Method of sequestering carbon dioxide from organic material using microwave radiation
Inventor: TURNEY IAN STEWART
IPC: C01B32/55
Filed: 2006-12-22
Abstract: Disclosed is a method for sequestering carbon dioxide comprising: cutting organic material (which is preferentially selected on the basis that it is well-suited to fix carbon) into chips (preferably in a chipper apparatus fuelled by bio-fuel) having dimensions in the range of 0.5 cm to 5 cm; carbonising the chips of organic material by applying microwave energy (preferably wherein the chips of organic material are held in oxygen-restricting containment when the microwave energy is applied using a solar-powered microwave apparatus); and storing the resulting charcoal in a carbon sink (such as a coal mine shaft, an open cast working mine, an exhausted oil reservoir or the carbon sink is in the form of terra preta soils). Also disclosed is a method for sequestering carbon dioxide comprising: machine-chipping plant material into chips having dimensions in the range of 0.5 cm to 5 cm, wherein the machinery used to chip the plant material is run on biofuel; and carbonising the chipped plant material in a solar-powered microwave oven; and storing the resulting charcoal in a carbon sink.
Patent NZ-552893-A (NZ)
Title: Unaerated food products containing hydrophobin
Inventor: ALDRED DEBORAH LYNNE
IPC: A23P30/40
Filed: 2005-06-27
Abstract: Disclosed is a frozen unaerated food product (such as a frozen confectionery product) comprising at least 0.001 wt% and less than 1 wt% hydrophobin in isolated form. Also disclosed is a method of inhibiting ice crystal growth in a frozen unaerated food product which method comprises adding hydrophobin to the product prior to and/or during freezing of the product.
Patent NZ-553105-A (NZ)
Title: Drain back water heater
Inventor: BOURKE BRENDAN VINCENT
IPC: F24H1/20
Filed: 2005-09-13
Abstract: A drain back water heater includes a hot water storage tank (100) with an internal heat exchanger (102). The heat exchanger (102) is in the form of a cylinder closed at the top by a cap .(104) and also closed at the base. A pump (110) draws off water from the bottom of the heat exchanger (102) circulates the heat transfer fluid back to the top of the heat exchanger at (112) when required. Attached to, or incorporated in the cap 104 is a falling film distributor (118) which serves to distribute the heat transfer fluid in a thin film around the inner wall of the heat exchanger (102). The heat transfer fluid can be heated in solar water heating panels. When the pump is turned off, the heat transfer fluid drains into the heat exchanger to at least partially fill the heat exchanger.
Patent NZ-560955-A (NZ)
Title: Fungicidal compositions and methods using cyanodithiocarbimates
Inventor: FENYES JOSEPH G E
IPC: C07C323/00
Filed: 2005-03-04
Abstract: Disclosed is a method for controlling the growth of at least one fungus on a tanned hide comprising the step of contacting a hide prior to, during or after tanning with a cyanodithiocarbimate of formula (I), wherein the variables shown in formula (I) are as defined in the specification. Particularly preferred cyanodithiocarbimate of formula (I) is hexyl chloromethyl cyanodithiocarbimate.
Patent NZ-568212-A (NZ)
Title: Changing Th1/Th2 balance in split influenza vaccines with adjuvants
Inventor: RAPPUOLI RINO
IPC: A61K39/39
Filed: 2006-11-06
Abstract: Disclosed is an immunogenic composition comprising a split influenza virus antigen when prepared from a virus grown in cell culture, and a Th1 adjuvant in the form of an oil-in-water emulsion comprising oil droplets having a submicron diameter, wherein said emulsion comprises squalene, and wherein said composition does not comprise any egg proteins. Also disclosed is the use of the composition in the manufacture of a medicament for raising an immune response against influenza virus in a subject. Further disclosed is a method for preparing the immunogenic composition said method comprising combining a split influenza virus antigen prepared from a virus grown in cell culture that does not comprise any egg proteins and a Th1 adjuvant in the form of an oil-in-water emulsion comprising oil droplets having a submicron diameter, wherein said emulsion comprises squalene
Patent NZ-577076-A (NZ)
Title: A turbine having a support and a housing that rotates about a point offset from the center of the support
Inventor: PERNER NORMAN
IPC: F03B13/26
Filed: 2008-02-09
Abstract: An underwater power station is disclosed. The station comprises a support structure (1), at least one turbine (3) and at least one electric machine (2) which can be operated as a generator or motor and which is in an at least indirect drive connection with the turbine (3). A spacer element (4) is between the turbine (3) and the support structure (1). The turbine is attached to one end of the support element (4), and there is a pivot joint (5) to the support structure (1) at the other end. The linkage point of the pivot joint (5) has an eccentricity in the form of a lateral offset (a) to the force action line of the propulsive power (13) which arises during the drive of the turbine (3) by means of the electric machine (2) in motive operation. This allows control of the direction of the turbine without the use of an additional electric motor.